002422 科倫藥業
按盤價 
41.980 -1.630 (-3.738%)
41.980 -1.630 (-3.738%) | 2026/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 4,259,245 | -2.98% | 18,512,919 | 21,812,414 | 21,453,929 | 19,038,216 | |
| 減：營業總成本 | 3,990,126 | 7.03% | 16,435,765 | 17,850,874 | 18,277,363 | 17,223,484 | |
| 其中:營業成本 | 2,329,223 | 3.37% | 9,655,237 | 10,536,821 | 10,205,535 | 9,040,158 | |
| 財務費用 | 11,708 | 183.70% | 71,499 | 66,179 | 233,761 | 479,834 | |
| 資產減值損失 | 0 | -- | (116,225) | (130,590) | (130,551) | (44,113) | |
| 公允價值變動收益 | 7,195 | -5.70% | 27,612 | 19,898 | 14,666 | 9,861 | |
| 投資收益 | 62,930 | 2.64% | 210,413 | 345,018 | 358,882 | 234,580 | |
| 其中：對聯營企業和合營企業的投資收益 | 59,165 | 1.00% | 182,889 | 320,466 | 352,105 | 228,194 | |
| 營業利潤 | 356,491 | -55.09% | 2,521,050 | 4,426,321 | 3,654,143 | 2,195,142 | |
| 利潤總額 | 441,048 | -42.96% | 2,403,836 | 4,285,359 | 3,580,426 | 2,067,919 | |
| 減：所得稅費用 | (31,652) | -127.86% | 526,624 | 923,404 | 933,787 | 363,697 | |
| 淨利潤 | 472,700 | -28.33% | 1,877,211 | 3,361,954 | 2,646,639 | 1,704,221 | |
| 減：非控股權益 | 19,000 | -74.78% | 175,276 | 426,062 | 190,527 | (1,103) | |
| 股東淨利潤 | 453,701 | -22.34% | 1,701,935 | 2,935,892 | 2,456,112 | 1,705,324 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.290 | -21.62% | 1.070 | 1.860 | 1.690 | 1.220 | |
| 每股派息 (元) * | -- | -- | 0.594 | 0.763 | 0.800 | 0.616 | |
| 每股淨資產 (元) * | 15.418 | 6.68% | 15.159 | 14.037 | 13.009 | 10.864 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 08/07/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
